Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Eur J Radiol ; 121: 108696, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31683251

ABSTRACT

PURPOSE: Ovarian cancer (OC) is the commonest cause of death by gynaecological cancer in developed countries. Peritoneal carcinomatosis (PC) complete debulking without residual disease of >1 cm is the best prognostic predictor in advanced OC. PC is assessed with Computed tomography (CT). CT accuracy and cytoreduction success predictive ability are limited. PET/CT is not an imaging standard for PC. PC shows high signal foci in Diffusion-weighted magnetic resonance imaging (DWI MRI). We assessed the diagnostic performance (DP) and tumour burden correlation of Whole body DWI with background suppression MRI (WB-DWIBS/MRI) in PC of suspected OC using the Peritoneal Cancer Index (PCI), referring to cytoreduction surgery as the standard reference. METHOD: Fifty patients with suspicion of disseminated OC underwent cytoreduction and WB-DWIBS/MRI. The PCI scores tumour burden (0-3) in 13 anatomical regions (global range of 0-39). Two radiologists (Rad1/Rad2) assessed the PCI preoperatively and with surgical findings. We evaluated regional and global DP, the interobserver agreement (Cohen´s kappa coefficient), statistical differences (McNemar test) and tumour burden (Pearson's test). RESULTS: 72% (36/50) were epithelial OC and 78% (39/50) achieved complete cytoreduction. Global-PCI correlation was 0.762 (Rad1) with DP: Sensitivity 0.84, specificity 0.89, accuracy 0.89, and kappa 0.41. Average global-PCI was 7. The pelvis and right hypochondrium showed the highest positive rate and DP, while the intestinal regions presented the lowest. Previous studies reported higher sensitivity than CT or PET/CT, although only a few used the PCI. CONCLUSIONS: WB-DWIBS/MRI is reliable to depict, quantify and to predict complete cytoreductive surgery in OC PC.


Subject(s)
Diffusion Magnetic Resonance Imaging/methods , Ovarian Neoplasms/pathology , Peritoneal Neoplasms/diagnostic imaging , Peritoneal Neoplasms/surgery , Cytoreduction Surgical Procedures , Female , Humans , Middle Aged , Neoplasm, Residual , Peritoneal Neoplasms/secondary , Peritoneum/diagnostic imaging , Peritoneum/surgery , Positron Emission Tomography Computed Tomography , Prognosis , Prospective Studies , Sensitivity and Specificity , Tomography, X-Ray Computed
2.
Arch Esp Urol ; 63(9): 803-7, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21098905

ABSTRACT

OBJECTIVE: We report a rare case of advanced testicular cancer that describes the natural progression of testicular cancer without medical treatment. This study also describes the effectiveness of chemotherapy, which was the approach used for treatment. METHODS: 37 year old male with history of mental retardation, presented to the emergency room with an ulcer on his right scrotum that had been present for a few months. He was diagnosed of pT4 embryonal carcinoma by biopsy. CT scan showed multiple lung nodes. He was treated with five cycles of Bleomycin/Etoposide/Cisplatin with complete response after treatment. RESULTS: Testicular tumors are the most frequent solid tumors in males between the ages of 20 and 39 years old. Testicular tumors represent 1% of all neoplasias diagnosed in males and 0.1% of all male deaths due to cancer. Several studies have reported the current real incidence rate of testicular tumors has increased to 3%, which accounts for the diagnosis of 450 new cases of testicular cancer a year in Spain. CONCLUSIONS: The cure rate for patients with intermediate risk non-seminoma is around 70% following a conventional treatment approach of four cycles of BEP. The present case is noteworthy because, in our experience, testicular tumors are diagnosed at an early stage without extensively affecting the skin or simulating another type of epithelial tumor. As a result, the present study describes the natural progression of testicular cancer.


Subject(s)
Carcinoma, Embryonal/pathology , Testicular Neoplasms/pathology , Adult , Carcinoma, Embryonal/drug therapy , Disease Progression , Humans , Male , Testicular Neoplasms/drug therapy
3.
Arch. esp. urol. (Ed. impr.) ; 63(9): 803-807, nov. 2010. ilus, tab
Article in Spanish | IBECS | ID: ibc-88720

ABSTRACT

OBJETIVO: Presentamos el caso de un varón de 37 años con un carcinoma embrionario en una forma poco frecuente en su debut, y que representa la historia natural de la enfermedad sin recibir atención sanitaria así como la efectividad del tratamiento con quimioterapia.MÉTODOS: Paciente de 37 años con antecedentes de retraso mental desde el nacimiento, acude a urgencias por presentar una masa escrotal ulcerada maloliente de meses de evolución. Tras biopsia es diagnosticado de carcinoma embrionario pT4; en el estudio de extensión se evidencian múltiples nódulos pulmonares compatibles con metástasis.Recibió un total de cinco ciclos de Bleomicina/Etoposido/Cisplatino con una respuesta total tras el tratamiento.RESULTADOS: Los tumores testiculares representan el tumor maligno sólido más frecuente en varones entre 20 y 39 años. Comprenden el 1% de todas las neoplasias masculina, y son responsables del 0,1% de todas las muertes por cáncer. Algunos autores apuntan que la incidencia real del tumor testicular ha aumentado y se sitúa alrededor del 3 % y se estima en 450 nuevos casos al año en España.CONCLUSIONES: Con respecto al pronóstico de los tumores no seminomatosos, se acepta que la tasa de curación de los pacientes de riesgo intermedio se sitúa alrededor del 70% con tratamiento convencional con cuatro ciclos de BEP. El caso que presentamos resulta muy llamativo puesto que en nuestro medio los tumores testiculares son diagnosticados en estadios iniciales, sin afectación cutánea extensa, ni simulando otros tipos de tumores epiteliales y muestra la historia natural de la enfermedad (AU)


OBJECTIVE: We report a rare case of advanced testicular cancer that describes the natural progression of testicular cancer without medical treatment. This study also describes the effectiveness of chemotherapy, which was the approach used for treatment.METHODS: 37 year old male with history of mental retardation, presented to the emergency room with an ulcer on his right scrotum that had been present for a few months. He was diagnosed of pT4 embryonal carcinoma by biopsy. CT scan showed multiple lung nodes. He was treated with five cycles of Bleomycin/Etoposide/Cisplatin with complete response after treatment.RESULTS: Testicular tumors are the most frequent solid tumors in males between the ages of 20 and 39 years old. Testicular tumors represent 1% of all neoplasias diagnosed in males and 0.1% of all male deaths due to cancer. Several studies have reported the current real incidence rate of testicular tumors has increased to 3%, which accounts for the diagnosis of 450 new cases of testicular cancer a year in Spain.CONCLUSIONS: The cure rate for patients with intermediate risk non-seminoma is around 70% following a conventional treatment approach of four cycles of BEP. The present case is noteworthy because, in our experience, testicular tumors are diagnosed at an early stage without extensively affecting the skin or simulating another type of epithelial tumor. As a result, the present study describes the natural progression of testicular cancer (AU)


Subject(s)
Humans , Male , Adult , Carcinoma, Embryonal/complications , Carcinoma, Embryonal/diagnosis , Carcinoma, Embryonal/pathology , Scrotum/anatomy & histology , Scrotum/injuries , Scrotum/pathology , Biopsy/instrumentation , Biopsy/methods , Biopsy , Tomography/methods , Tomography
4.
Clin Transl Oncol ; 12(9): 606-13, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20851801

ABSTRACT

Conventional diagnostic magnetic resonance imaging (MRI) techniques have focused on improving the spatial resolution and image acquisition speed (whole-body MRI) or on new contrast agents. Most advances in MRI go beyond morphologic study to obtain functional and structural information in vivo about different physiological processes of tumor microenvironment, such as oxygenation levels, cellular proliferation, or tumor vascularization through MRI analysis of some characteristics: angiogenesis (perfusion MRI), metabolism (MRI spectroscopy), cellularity (diffusion-weighted MRI), lymph node function, or hypoxia [blood-oxygen-level-dependent (BOLD) MRI]. We discuss the contributions of different MRI techniques than must be integrated in oncologic patients to substantially advance tumor detection and characterization risk stratification, prognosis, predicting and monitoring response to treatment, and development of new drugs.


Subject(s)
Magnetic Resonance Imaging , Neoplasms/diagnosis , Cell Hypoxia , Diffusion Magnetic Resonance Imaging , Humans , Lymph Nodes/pathology , Magnetic Resonance Angiography , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy , Neoplasms/metabolism , Prognosis , Treatment Outcome , Whole Body Imaging
5.
Cancer J ; 15(3): 184-9, 2009.
Article in English | MEDLINE | ID: mdl-19556902

ABSTRACT

Imaging studies are crucial in the evaluation of patients with suspected or known peritoneal cancerous dissemination. Despite the major progress that has occurred in radiological technology in the last few years, adequate and early detection of peritoneal surface disease remains a challenge. Improvements in spatial resolution are still insufficient to detect small volume peritoneal implants, often resulting in an underestimation of peritoneal disease burden, as assessed at subsequent surgical exploration. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy has provided unprecedented results in the management of peritoneal-based neoplasms, provided that a complete (adequate) cytoreduction is achieved. Diagnostic imaging tests are used to select patients who may benefit from this combined treatment by ruling out extraperitoneal involvement and signs of unresectable peritoneal disease. Furthermore, a careful assessment of the disease distribution within the peritoneal cavity, guided by a deep knowledge of the disease's clinical and biological behavior helps in planning the surgical procedure. Close interaction and cooperation between surgeons and radiologists is of utmost importance in this regard, and dedicated, motivated radiologists are required. Contrast-enhanced, multidetector computed tomography scan remains the standard imaging modality in the assessment of peritoneal carcinomatosis. Magnetic resonance imaging may offer complementary valuable data. Positron emission tomography (PET) has a more limited role, its main indication being the detection of unsuspected extraperitoneal involvement in nonmucinous neoplasms.


Subject(s)
Peritoneal Neoplasms/diagnostic imaging , Tomography, X-Ray Computed , Humans , Magnetic Resonance Imaging , Positron-Emission Tomography
SELECTION OF CITATIONS
SEARCH DETAIL
...